beta

CERS

Cerus Corp.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.

Market Cap: 959 Million

Primary Exchange: NASDAQ

Website: http://www.cerus.com

Shares Outstanding: 164 Million

Float: 160 Million

Dividend: (%)

Beta: 1.10004771266373

Sector: Health Technology

Industry: Medical Specialties

Ethical Flags

Longest drawdown: 2161 trading days

From: 2014-02-25 To: 2020-06-04

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud